WindRose Health Investors Achieves Major Fundraising Success with $2.6 Billion for Fund VII

In a significant move for the healthcare investment landscape, WindRose Health Investors, LLC, a private equity firm located in New York, has successfully closed its seventh fund, titled WindRose Health Investors VII, L.P. This monumental fund has garnered a total commitment of $2.6 billion from both limited and general partners, marking a notable achievement in the firm's history. This amount surpasses the size of its predecessor fund, Fund VI, which raised $1.4 billion.

Oliver T. Moses, the Managing Partner at WindRose, expressed gratitude for the unwavering support from existing investors and welcomed a diverse array of new investors from around the globe, including the Americas, Europe, the Middle East, and Asia. In his statement, Moses highlighted the quick six-month timeframe required to close Fund VII, a testament to the confidence investors placed in WindRose’s capabilities. He remarked, "We are now eager to get to work on our latest fund and are optimistic about continued opportunities to invest in innovative, tech-enabled businesses that are improving quality and enhancing efficiency in healthcare."

The closure of Fund VII is particularly notable given the current challenging fundraising environment. According to Catherine Coleman, the Head of Investor Relations, WindRose appreciates its investors' ongoing commitment, which has proven essential for success in these trying times. "We believe that our value creation capabilities are well-suited to meet the evolving demands of the healthcare industry, offering our portfolio companies a distinct competitive advantage in their pursuit of innovation and growth," she stated.

Fund VII aims to secure a total of 11-13 investments and is already making strides towards its initial acquisitions, expecting to close on two deals before the year ends in 2025. The fund attracted a wide mix of institutional investors, including pension funds, insurance companies, banks, foundations, fund-of-funds, and family offices, showcasing the strong market confidence in the firm's strategic direction.

As the healthcare sector continues to navigate complexities, WindRose is poised to leverage its extensive industry expertise to identify and nurture opportunities that align with its investment strategy. The firm particularly seeks out companies that operate within the service sectors of healthcare and those with proven business models that offer cost-effective solutions to pressing health challenges.

WindRose currently manages approximately $7 billion in assets, focusing on investments throughout the United States. With an eye toward building lasting relationships and fostering innovation, the firm aims to make a significant impact in the healthcare investment domain.

To ensure that investors are well-informed, WindRose engaged the services of Evercore Private Funds Group as its exclusive global placement agent, with Kirkland & Ellis LLP serving as counsel to the fund.

As WindRose embarks on this latest venture, it remains steadfast in its commitment to delivering superior investment outcomes while enhancing the efficiency and quality of healthcare services. The firm invites interested parties to reach out for more information about its investment strategies and success stories.

For further inquiries, you may contact Caroline Luz at Lambert by LLYC by calling 203-570-6462 or via email at [email protected].